Michael Keefe

Michael Keefe, a partner at Six.02 Bioservices (www.six02bio.com), has more than 20 years of leadership experience in the bioservices industry. Most recently, at A&G Pharmaceutical, he secured significant private equity and strategic investment that enabled the company’s therapeutic division to move from candidate R&D to “first in human” clinical trials. Concurrently, Mike oversaw the sales and marketing operations of A&G’s antibody development service division, Precision Antibody Services. During his nine-year tenure as Chief Operating Officer for Precision Antibody, he grew the division from start-up into a multimillion-dollar revenue center. He received a BBA in Finance from the University of Notre Dame and an MBA from Northwestern University’s Kellogg School of Management.